Related Experiment Video
Updated: May 2, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.7K
Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation?
G M Ettorre1, A Laurenzi1, G Vennarecci1
1General Surgery and Liver Transplantation, San Camillo Hospital, Circ. ne Gianicolense 87, 00151 Rome, Italy.
Abstract:
Trans Arterial Radio Embolization with Yttrium 90 in the treatment of Hepatocellular Carcinoma is becoming a new interesting tool in the treatment of patients that are considered non resectable and non transplantable. A successful downstaging could improve the number of patients that could benefit from a resection or a liver transplantation, but some points still need to be addressed.

